top of page
Search

The £30,000 Cost of Waiting: Why Delayed Detection is Failing Us All

  • Writer: Jonathan Sabarre
    Jonathan Sabarre
  • Aug 14
  • 3 min read
ree

Dementia isn’t just a personal tragedy — it’s an economic one.

Every year in the UK, dementia costs our economy £42 billion, with over 944,000 people currently living with the condition. But what’s even more shocking is the cost of waiting. For every year that early detection is delayed, the average economic burden increases by £30,000 per patient.

That cost includes not just healthcare, but lost productivity, care home placement, emergency admissions, and unpaid family care. And yet, despite this staggering impact, diagnosis still comes late — often years after the first signs appear.

At SynaptiSense, we believe that early detection isn’t a luxury — it’s a financial, medical, and human necessity.


Why Diagnosis Comes Too Late

Right now, dementia is typically diagnosed after family members notice memory lapses, confusion, or behavioural changes. From there, the patient is referred to a memory clinic — a process that can take months. By that point, the cognitive decline is often irreversible, and the window for effective intervention has closed.

The result?

  • Emergency care becomes more likely

  • More intensive (and expensive) support is needed

  • Families face emotional and financial strain

  • The NHS is stretched beyond capacity

And still, early detection methods remain limited — costly MRI scans, hard-to-access specialist services, or subjective cognitive tests. There’s a clear gap in the system. And it’s costing everyone.


A Preventable Financial Burden

Let’s break down what that £30,000/year figure includes:

  • Specialist consultations

  • Hospital stays and outpatient services

  • Residential care and home assistance

  • Support for family carers (unpaid or underpaid)

  • Prescriptions and psychiatric interventions

  • Lost earnings due to early retirement or job loss

Many of these costs can be reduced — or even avoided — through earlier detection and smarter planning.

Early diagnosis allows:

  • Timely intervention that can delay disease progression

  • Lower-cost, community-based support

  • Better coordination of care

  • More informed, proactive decision-making


The SynaptiSense Solution

SynaptiSense is developing a tool that flips the model. Rather than waiting for visible decline, our platform uses AI to detect dementia 5–7 years before symptoms appear — via non-invasive, everyday interactions.

We analyse four data streams:

  1. Speech patterns — subtle linguistic changes invisible to the ear

  2. Cognitive games — tracking memory, speed, and adaptability over time

  3. Wearable health data — such as sleep, step count, and heart rate variability

  4. Behavioural signals — consistent usage patterns and changes in routine

This approach has already achieved 96% accuracy in wearable trials and shown strong engagement from early testers. Our system doesn’t require hospital visits, referrals, or expensive imaging — it’s affordable, accessible, and designed for daily life.


It’s Not Just the NHS That Pays

Families bear the brunt of delayed diagnosis:

  • Loss of independence and mobility

  • Career disruptions for carers

  • Emotional burnout and mental health issues

  • Legal and financial planning under pressure

Early detection provides time to:

  • Prepare legally and financially

  • Access appropriate support and respite care

  • Begin lifestyle changes that may delay progression

  • Make decisions together, rather than in crisis

That peace of mind is priceless — but it also makes economic sense.


🎯 It’s Time to Change the Model

Delaying diagnosis doesn’t save money. It shifts the cost to a later stage — when it’s higher, harder to manage, and more painful for families.

SynaptiSense is on a mission to reduce these costs by identifying dementia earlier, giving patients and families more time to act, and enabling a proactive rather than reactive system.


📣 Join the Early Access List

We’re preparing for launch — and you can be part of it:

  • Get first access to our early detection app

  • Help shape the future of preventative brain health

  • Receive updates and insights from our clinical trials

Don’t let time cost you £30,000 — or more.👉 Sign up here for early access to SynaptiSense


 
 
 

Comments


Heading (1)_edited.png
Empowering Healthcare Professionals

SYNAPTISENSE LTD

Company No: 16393407

+44737 696 0096

3rd Floor, 86-90 Paul Street, London, England, EC2A 4NE

Heading (1)_edited.png

 

© 2025 by SynaptiSense. 

 

bottom of page